Person: GÜRSOY, AZIZE ESRA
4 results
Search Results
Now showing 1 - 4 of 4
Publication Open Access Lambert-Eaton Myasthenic Syndrome with A Twenty-Three-Year Delay in Diagnosis(2017-06-01) Gokcal, ELİF; Gürsoy, AZİZE ESRA; Asil, TALİP; Ertas, Mustafa; GÖKÇAL, ELİF; GÜRSOY, AZIZE ESRA; ASİL, TALIPLambert-Eaton myasthenic syndrome (LEMS) is a rare neuromuscular junction disorder resulting from the development of auto-antibodies against voltage-gated calcium channels (VGCCs) in pre-synaptic terminals (1). It has tumoral and non-tumoral forms; the former is associated with small cell lung cancer. Clinically, it is characterized by proximal weakness, autonomic symptoms, and loss/reduction of deep tendon reflexes (2). Muscular weakness, frequently occurring in the lower extremities, almost always begins symmetrically in the proximal muscles, progressing to involve the distal muscles over time (3). It may be confused with myopathic disorders due to the presence of symmetrical muscular weakness involving the proximal muscles. Herein we present the case of a non-tumoral LEMS patient who was diagnosed as having myopathy due to weakness that started in the legs nearly 23 years ago. Written consent was taken from the patientPublication Open Access Prophylactic Treatment of Migraine(2013-08-01T00:00:00Z) Gürsoy, AZİZE ESRA; ERTAŞ, M; GÜRSOY, AZIZE ESRAMigraine is a common chronic neurological disease characterized by episodic attacks of headache and associated symptoms. The pharmacological treatment of migraine may be acute or prophylactic, and patients with frequent, severe headaches often require both approaches. Prophylactic treatment is used to reduce the frequency, duration, or severity of attacks, to enhance the benefits of acute treatments, and to improve patient's ability to function normally. Prophylactic treatment may also prevent progression from episodic migraine to chronic migraine and may result in reductions in health-care cost. The currently available pharmacological options for migraine prophylaxis include a wide array of medications. The major medication groups for prophylactic treatment include beta-blockers, anticonvulsant, drugs such as topiramate and valproate, antidepressant drugs, such as amitriptyline and selective serotonin and selective serotonin-norepinephrine reuptake inhibitors (SNRIs), calcium channel antagonists and neurotoxins. The agent for prophylactic treatment should be chosen based on the efficacy and side-effect profile of the drug, and the patient's coexistent and comorbid conditions.Publication Open Access Relationship between electrodiagnostic severity and neuropathic pain assessed by the LANSS pain scale in carpal tunnel syndrome.(2013-01-01T00:00:00Z) KOLUKISA, MEHMET; Gürsoy, AZİZE ESRA; YıLDıZ, GB; KOCAMAN, G; CELEBI, A; KOÇER, A; GÜRSOY, AZIZE ESRA; KOLUKISA, MEHMET; BABACAN YILDIZ, GÜLSENObjective: The aim of the study was to investigate the relationship between the presence of neuropathic pain assessed by the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scale and electrophysiological findings in patients with carpal tunnel syndrome (CTS). Methods: We studied 124 hands with idiopathic CTS with pain complaints involving hand and wrist. All hands were assessed by the LANSS with which a score of 12 or more is defined as pain dominated by neuropathic mechanisms. These hands were assigned to minimal, mild, moderate, severe, or extreme severe groups according to the results of the median nerve conduction studies. Results: A LANSS score $ 12, suggestive of pain dominated by neuropathic mechanisms, was defined in 59 (47.6%) CTS hands. Pain intensity was significantly higher in CTS hands with a LANSS score $ 12 (P , 0.001). Among electrophysiological findings, compound muscle action potential amplitude was significantly lower in hands with a LANSS score $ 12 compared with hands with a LANSS score , 12 (P = 0.020). Severity of CTS was not significantly different between LANSS $ 12 and LANSS , 12 groups. Electrophysiological severity was significantly higher in CTS hands with evoked pain (P = 0.005) and allodynia (P , 0.001) in LANSS subscore analysis. Conclusion: We suggest that the presence of pain dominated by neuropathic mechanisms in CTS is not related to electrophysiological CTS severity. Neuropathic pain should be assessed carefully in patients with CTS, and an appropriate treatment plan should be chosen, taking into account the clinical and electrophysiological findings together with the true pain classification. Keywords: electrodiagnostic evaluation, carpal tunnel syndrome, LANSS, neuropathic painPublication Metadata only Idiopathic spinal accessory nerve palsy: A case report and review of the literature.(2013-01-01T00:00:00Z) Gürsoy, AZİZE ESRA; BABACAN-YıLDıZ, G; KOLUKıSA, MEHMET; CELEBI, A; GÜRSOY, AZIZE ESRA; BABACAN YILDIZ, GÜLSEN; KOLUKISA, MEHMET